LATANOPROSTENE BUNOD

LATANOPROSTENE BUNOD was reported 1146 times

LATANOPROSTENE BUNOD is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EPIRETINAL MEMBRANE PEEL 1 0.1667
1 INSTILLATION SITE HYPOAESTHESIA 1 0.1429
2 GLAUCOMA DRAINAGE DEVICE EXPOSURE 1 0.1250
3 CHOROIDAL HAEMANGIOMA 1 0.1250
4 CONJUNCTIVAL LACERATION 1 0.1000
5 LASER SURGERY 2 0.0714
6 SEBACEOUS CYST EXCISION 1 0.0667
7 CORNEAL LACERATION 1 0.0556
8 INSTILLATION SITE INFLAMMATION 3 0.0536
9 MYOPIC CHORIORETINAL DEGENERATION 1 0.0455
10 TEAR BREAK UP TIME DECREASED 1 0.0455
11 RETIREMENT 1 0.0400
12 INSTILLATION SITE DISCOMFORT 5 0.0373
13 SNAPPING HIP SYNDROME 1 0.0357
14 BLEPHARITIS ALLERGIC 1 0.0323
15 INSTILLATION SITE DRYNESS 3 0.0233
16 INSTILLATION SITE BURN 1 0.0233
17 PERIORBITAL FAT ATROPHY 1 0.0233
18 IRIS DISCOLOURATION 1 0.0217
19 INSTILLATION SITE PRURITUS 8 0.0212
20 INSTILLATION SITE ERYTHEMA 11 0.0208
21 OTOLITHIASIS 1 0.0204
22 EYELID DISCOLOURATION 1 0.0196
23 PRODUCT CLOSURE REMOVAL DIFFICULT 18 0.0176
24 GLAUCOMA DRAINAGE DEVICE PLACEMENT 1 0.0172
25 INSTILLATION SITE LACRIMATION 4 0.0165
26 EYELID CONTUSION 1 0.0149
27 INSTILLATION SITE FOREIGN BODY SENSATION 2 0.0138
28 INSTILLATION SITE IRRITATION 16 0.0135
29 MIXED DEAFNESS 1 0.0127
30 CORNEAL IRRITATION 1 0.0125
31 TRABECULECTOMY 1 0.0109
32 PIGMENT DISPERSION SYNDROME 1 0.0105
33 CORNEAL BLEEDING 1 0.0104
34 INTRAOCULAR PRESSURE FLUCTUATION 2 0.0102
35 INTRAOCULAR PRESSURE TEST ABNORMAL 7 0.0099
36 EAR LOBE INFECTION 1 0.0098
37 CORNEAL OPERATION 1 0.0097
38 INJECTION SITE JOINT PAIN 1 0.0093
39 INSTILLATION SITE PAIN 22 0.0089
40 NORMAL TENSION GLAUCOMA 1 0.0086
41 CHARLES BONNET SYNDROME 1 0.0083
42 HYPERADRENALISM 1 0.0082
43 INSTILLATION SITE DISCHARGE 2 0.0076
44 GROWTH OF EYELASHES 6 0.0076
45 OCULAR STROKE 1 0.0072
46 CYSTOID MACULAR OEDEMA 13 0.0069
47 MEDICAL DEVICE SITE REACTION 1 0.0063
48 EYE INFECTION VIRAL 2 0.0062
49 OPEN GLOBE INJURY 1 0.0061
50 PANOPHTHALMITIS 1 0.0055
51 LID SULCUS DEEPENED 2 0.0054
52 CONJUNCTIVAL DISORDER 2 0.0052
53 CHOROIDAL HAEMORRHAGE 1 0.0052
54 OCULAR PROCEDURAL COMPLICATION 1 0.0052
55 INTRAOCULAR PRESSURE INCREASED 63 0.0049
56 EYELID PAIN 10 0.0049
57 PERIORBITAL DISORDER 1 0.0049
58 CORNEAL GRAFT REJECTION 1 0.0048
59 POST PROCEDURAL HYPOTHYROIDISM 1 0.0047
60 DUODENAL POLYP 1 0.0047
61 SPLINTER 1 0.0043
62 PERIORBITAL INFLAMMATION 1 0.0043
63 OPHTHALMIC MIGRAINE 3 0.0043
64 PRODUCT DELIVERY MECHANISM ISSUE 23 0.0043
65 ABSENCE OF IMMEDIATE TREATMENT RESPONSE 1 0.0042
66 EUSTACHIAN TUBE DISORDER 1 0.0042
67 CORNEAL DEGENERATION 1 0.0041
68 INCISION SITE DISCHARGE 1 0.0040
69 EYE COLOUR CHANGE 4 0.0039
70 GLAUCOMA SURGERY 1 0.0039
71 KERATOMILEUSIS 1 0.0039
72 CORNEAL TRANSPLANT 3 0.0038
73 NASAL INFLAMMATION 4 0.0038
74 BACTERIAL ENDOPHTHALMITIS 1 0.0038
75 ANION GAP ABNORMAL 1 0.0037
76 STEATOHEPATITIS 2 0.0037
77 SCLERAL DISORDER 1 0.0037
78 REACTION TO PRESERVATIVES 3 0.0037
79 CONJUNCTIVAL HYPERAEMIA 13 0.0036
80 HYPERADRENOCORTICISM 1 0.0036
81 EPIRETINAL MEMBRANE 1 0.0036
82 OCULAR SURFACE DISEASE 1 0.0036
83 HYPERAEMIA 7 0.0035
84 EYELID MARGIN CRUSTING 10 0.0035
85 BLOOD IMMUNOGLOBULIN G INCREASED 4 0.0033
86 CHORIORETINITIS 2 0.0031
87 HEMIPLEGIC MIGRAINE 1 0.0029
88 CAROTID ARTERY ANEURYSM 1 0.0029
89 PERIORBITAL IRRITATION 1 0.0029
90 POSTERIOR CAPSULE OPACIFICATION 1 0.0029
91 FOREIGN BODY SENSATION IN EYES 18 0.0028
92 CONJUNCTIVITIS ALLERGIC 4 0.0027
93 TOTAL LUNG CAPACITY ABNORMAL 1 0.0026
94 NEUTROPHILIC DERMATOSIS 1 0.0025
95 EYELID EXFOLIATION 2 0.0025
96 EYE INFECTION TOXOPLASMAL 1 0.0025
97 CHOROIDAL EFFUSION 2 0.0025
98 MANUFACTURING MATERIALS ISSUE 1 0.0025
99 NAIL OPERATION 1 0.0024
100 GIANT CELL ARTERITIS 2 0.0024
101 HYPOTONY OF EYE 1 0.0024
102 OTITIS MEDIA CHRONIC 1 0.0024
103 EXPOSURE VIA EYE CONTACT 1 0.0024
104 ABDOMINAL CAVITY DRAINAGE 1 0.0024
105 PERIORBITAL PAIN 2 0.0024
106 VITAMIN B1 DEFICIENCY 1 0.0023
107 ENDOCRINE OPHTHALMOPATHY 2 0.0023
108 FUNGAL FOOT INFECTION 1 0.0023
109 REFLUX LARYNGITIS 1 0.0023
110 EYE PAIN 120 0.0021
111 PRODUCT AFTER TASTE 2 0.0021
112 PATIENT DISSATISFACTION WITH TREATMENT 4 0.0021
113 EYELID RASH 2 0.0020
114 DARK CIRCLES UNDER EYES 3 0.0020
115 EYELID IRRITATION 5 0.0020
116 CORNEAL SCAR 1 0.0020
117 PRODUCT CONTAINER ISSUE 17 0.0020
118 BLEPHARAL PIGMENTATION 1 0.0020
119 GLARE 1 0.0019
120 IRIS ADHESIONS 1 0.0019
121 CONJUNCTIVAL OEDEMA 2 0.0019
122 HYPHAEMA 1 0.0019
123 PRODUCT PACKAGING DIFFICULT TO OPEN 5 0.0019
124 EYE IRRITATION 110 0.0019
125 INTRAOCULAR PRESSURE DECREASED 1 0.0019
126 EXPULSION OF MEDICATION 1 0.0019
127 OCULAR DISCOMFORT 21 0.0019
128 ERYTHEMA OF EYELID 10 0.0018
129 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
130 PRODUCT PACKAGE ASSOCIATED INJURY 4 0.0018
131 EYE INFECTION BACTERIAL 1 0.0018
132 COLECTOMY TOTAL 1 0.0018
133 MEDICAL DEVICE REMOVAL 3 0.0017
134 EYELID DISORDER 4 0.0017
135 CORNEAL EPITHELIUM DEFECT 1 0.0017
136 OCULAR HYPERAEMIA 81 0.0017
137 HYPOAESTHESIA EYE 1 0.0017
138 EYE LASER SURGERY 1 0.0017
139 ANTERIOR CHAMBER INFLAMMATION 1 0.0017
140 VITRECTOMY 1 0.0017
141 IRITIS 5 0.0016
142 DIAPHRAGMATIC HERNIA 1 0.0016
143 SWELLING OF EYELID 10 0.0016
144 IRIDOCYCLITIS 5 0.0016
145 INCREASED VISCOSITY OF BRONCHIAL SECRETION 1 0.0016
146 SCLERAL DISCOLOURATION 1 0.0015
147 EYE OPERATION 7 0.0015
148 INABILITY TO AFFORD MEDICATION 15 0.0015
149 BLEPHARITIS 6 0.0015
150 PRECANCEROUS CONDITION 1 0.0015
151 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
152 VITREOUS FLOATERS 14 0.0014
153 GLASSY EYES 1 0.0014
154 PRODUCT DESIGN ISSUE 1 0.0014
155 IMMUNISATION REACTION 1 0.0014
156 CORNEAL DISORDER 3 0.0014
157 CLOSTRIDIUM TEST POSITIVE 3 0.0014
158 GLAUCOMA 26 0.0013
159 CORNEAL OEDEMA 3 0.0013
160 MYASTHENIC SYNDROME 1 0.0013
161 EYE ALLERGY 2 0.0013
162 EYELIDS PRURITUS 4 0.0013
163 DRUG TOLERANCE INCREASED 1 0.0013
164 BLISTER INFECTED 1 0.0013
165 PHOTOPHOBIA 24 0.0013
166 MUSCLE DISCOMFORT 1 0.0013
167 ASTHENOPIA 7 0.0013
168 EYE INFLAMMATION 12 0.0013
169 WRONG DOSE 3 0.0012
170 SEROUS RETINAL DETACHMENT 1 0.0012
171 CHOROIDAL NEOVASCULARISATION 1 0.0012
172 TREATMENT DELAYED 2 0.0012
173 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
174 PUNCTATE KERATITIS 1 0.0011
175 MACULAR OEDEMA 6 0.0011
176 BLOOD UREA ABNORMAL 1 0.0011
177 CONJUNCTIVAL HAEMORRHAGE 4 0.0010
178 FOREIGN BODY IN EYE 1 0.0010
179 CORRECTIVE LENS USER 1 0.0010
180 BREAST DISCOMFORT 1 0.0010
181 PHOTOPSIA 6 0.0009
182 AMYLOID RELATED IMAGING ABNORMALITY-MICROHAEMORRHAGES AND HAEMOSIDERIN DEPOSITS 1 0.0009
183 NAIL GROWTH ABNORMAL 1 0.0009
184 CARDIAC AMYLOIDOSIS 1 0.0009
185 GASTROINTESTINAL HYPOMOTILITY 2 0.0009
186 T-CELL LYMPHOMA 1 0.0009
187 SURGICAL FAILURE 1 0.0009
188 OPTIC NERVE INJURY 1 0.0009
189 CATARACT OPERATION 5 0.0008
190 SKIN WEEPING 3 0.0008
191 EYE PRURITUS 28 0.0008
192 VISUAL FIELD DEFECT 6 0.0008
193 EYELID SKIN DRYNESS 1 0.0008
194 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
195 LACRIMATION INCREASED 24 0.0008
196 HYPERAESTHESIA TEETH 1 0.0008
197 LIP DISCOLOURATION 1 0.0008
198 IMPAIRED DRIVING ABILITY 9 0.0008
199 CARDIAC VENTRICULAR THROMBOSIS 1 0.0008
200 ABDOMINAL OPERATION 1 0.0008
201 HERPES OPHTHALMIC 1 0.0008
202 PRODUCT DISTRIBUTION ISSUE 7 0.0008
203 MACULAR HOLE 1 0.0007
204 CARBON DIOXIDE INCREASED 1 0.0007
205 CORNEAL OPACITY 1 0.0007
206 INFUSION SITE RASH 1 0.0007
207 GLOMERULAR FILTRATION RATE ABNORMAL 1 0.0007
208 PRODUCT USE COMPLAINT 11 0.0007
209 ABNORMAL SENSATION IN EYE 3 0.0007
210 POST HERPETIC NEURALGIA 1 0.0007
211 ANKLE OPERATION 1 0.0007
212 EYE DISCHARGE 7 0.0007
213 UVEITIS 9 0.0007
214 KERATITIS 2 0.0007
215 TRANSCRIPTION MEDICATION ERROR 1 0.0006
216 PHARYNGEAL PARAESTHESIA 1 0.0006
217 COSTOCHONDRITIS 1 0.0006
218 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
219 INJECTION RELATED REACTION 1 0.0006
220 SEBORRHOEIC DERMATITIS 1 0.0006
221 SUPRAVENTRICULAR EXTRASYSTOLES 2 0.0006
222 SPINAL CORD INJURY 1 0.0006
223 PANCREATIC FAILURE 1 0.0006
224 DRY EYE 28 0.0006
225 VENOUS OCCLUSION 1 0.0005
226 SUSPECTED PRODUCT QUALITY ISSUE 1 0.0005
227 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
228 NASAL OBSTRUCTION 1 0.0005
229 ATROPHY 1 0.0005
230 EXPIRED PRODUCT ADMINISTERED 17 0.0005
231 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
232 DRUG DELIVERY SYSTEM ISSUE 1 0.0005
233 NASAL DISCOMFORT 4 0.0005
234 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
235 REBOUND ATOPIC DERMATITIS 1 0.0005
236 EAR SWELLING 1 0.0005
237 TEARFULNESS 2 0.0005
238 EXPOSURE VIA SKIN CONTACT 12 0.0005
239 INFUSION SITE BRUISING 1 0.0005
240 INSURANCE ISSUE 7 0.0005
241 ONYCHOMYCOSIS 2 0.0005
242 PRODUCT LOT NUMBER ISSUE 1 0.0005
243 CALCINOSIS 1 0.0004
244 FEAR OF DEATH 1 0.0004
245 OROPHARYNGEAL DISCOMFORT 4 0.0004
246 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
247 REACTION TO EXCIPIENT 1 0.0004
248 PUSTULE 1 0.0004
249 WEIGHT ABNORMAL 1 0.0004
250 PULSE ABNORMAL 1 0.0004
251 BREATH ODOUR 1 0.0004
252 EYE OEDEMA 1 0.0004
253 CATHETER SITE HAEMORRHAGE 1 0.0004
254 RETINAL ARTERY OCCLUSION 1 0.0004
255 EYE DISORDER 13 0.0004
256 ILEOSTOMY 1 0.0004
257 HYPOGLYCAEMIA 19 0.0004
258 PRODUCT TEMPERATURE EXCURSION ISSUE 2 0.0004
259 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
260 LIPOMA 1 0.0004
261 BRAIN FOG 6 0.0004
262 BLOOD POTASSIUM ABNORMAL 1 0.0004
263 YAWNING 1 0.0004
264 HYPERLACTACIDAEMIA 1 0.0004
265 PRODUCT RESIDUE PRESENT 2 0.0004
266 SKIN DISCOMFORT 1 0.0004
267 MIGRAINE WITH AURA 1 0.0004
268 CLUMSINESS 1 0.0004
269 ORAL FUNGAL INFECTION 1 0.0004
270 ULCERATIVE KERATITIS 1 0.0004
271 THERAPEUTIC RESPONSE DELAYED 1 0.0004
272 VISION BLURRED 49 0.0004
273 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 12 0.0004
274 EYE INFECTION 4 0.0004
275 SEASONAL ALLERGY 5 0.0004
276 CEREBRAL THROMBOSIS 1 0.0004
277 PANCREATIC CARCINOMA METASTATIC 1 0.0004
278 DIPLOPIA 9 0.0003
279 HAEMOTHORAX 1 0.0003
280 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
281 BURNING SENSATION 24 0.0003
282 VISUAL IMPAIRMENT 42 0.0003
283 URINARY INCONTINENCE 10 0.0003
284 SINUS HEADACHE 2 0.0003
285 CREPITATIONS 1 0.0003
286 VARICES OESOPHAGEAL 1 0.0003
287 CONJUNCTIVITIS 6 0.0003
288 FAMILY STRESS 1 0.0003
289 BLEPHAROSPASM 2 0.0003
290 INFUSION SITE PRURITUS 1 0.0003
291 PLASMA CELL MYELOMA RECURRENT 1 0.0003
292 POSTURE ABNORMAL 1 0.0003
293 PRODUCT AVAILABILITY ISSUE 7 0.0003
294 HEPATIC NEOPLASM 1 0.0003
295 PRODUCT LABEL ISSUE 2 0.0003
296 SLUGGISHNESS 3 0.0003
297 DROOLING 2 0.0003
298 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
299 BLOOD CREATININE ABNORMAL 1 0.0003
300 HYPOPNOEA 1 0.0003
301 HYPERTRANSAMINASAEMIA 2 0.0003
302 PRODUCT QUALITY ISSUE 39 0.0003
303 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
304 BLINDNESS UNILATERAL 4 0.0003
305 PRODUCT CONTAMINATION 1 0.0003
306 RETINAL HAEMORRHAGE 2 0.0003
307 THERAPY INTERRUPTED 20 0.0003
308 SKIN LACERATION 3 0.0003
309 ARTHROPOD BITE 2 0.0003
310 EYE SWELLING 10 0.0003
311 CHRONIC SINUSITIS 1 0.0003
312 PARANASAL SINUS DISCOMFORT 1 0.0003
313 PRODUCT STORAGE ISSUE 1 0.0003
314 PRODUCT STORAGE ERROR 23 0.0003
315 COMMUNICATION DISORDER 1 0.0003
316 BOWEL MOVEMENT IRREGULARITY 2 0.0003
317 OESOPHAGEAL DISORDER 1 0.0003
318 MADAROSIS 3 0.0003
319 EPIGASTRIC DISCOMFORT 1 0.0003
320 WOUND SECRETION 1 0.0003
321 MULTIPLE ALLERGIES 2 0.0003
322 NAIL DISCOLOURATION 1 0.0003
323 BLOOD PRESSURE FLUCTUATION 6 0.0002
324 PRODUCT ADMINISTRATION ERROR 5 0.0002
325 SPINAL FUSION SURGERY 1 0.0002
326 TASTE DISORDER 5 0.0002
327 BLINDNESS 10 0.0002
328 PERIPHERAL VENOUS DISEASE 1 0.0002
329 GOITRE 1 0.0002
330 VISUAL ACUITY REDUCED 8 0.0002
331 SUICIDAL BEHAVIOUR 1 0.0002
332 INFUSION SITE ERYTHEMA 2 0.0002
333 PRODUCT COMPLAINT 6 0.0002
334 TONGUE DISCOMFORT 1 0.0002
335 POOR PERIPHERAL CIRCULATION 1 0.0002
336 ABSCESS LIMB 1 0.0002
337 TENSION HEADACHE 1 0.0002
338 POOR QUALITY SLEEP 5 0.0002
339 HEPATIC LESION 1 0.0002
340 HORDEOLUM 1 0.0002
341 MONOPLEGIA 1 0.0002
342 IMMOBILE 1 0.0002
343 DIVERTICULUM INTESTINAL 1 0.0002
344 TONGUE DISCOLOURATION 1 0.0002
345 FACIAL PAIN 2 0.0002
346 URINE ABNORMALITY 1 0.0002
347 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
348 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
349 RENAL FUNCTION TEST ABNORMAL 1 0.0002
350 VAGINAL INFECTION 1 0.0002
351 COLITIS MICROSCOPIC 1 0.0002
352 BLOOD URINE PRESENT 4 0.0002
353 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
354 PRODUCT PRESCRIBING ERROR 5 0.0002
355 SUBCUTANEOUS ABSCESS 1 0.0002
356 DIZZINESS POSTURAL 2 0.0002
357 PHARYNGEAL SWELLING 2 0.0002
358 EYELID PTOSIS 2 0.0002
359 DRY THROAT 2 0.0002
360 EAR DISCOMFORT 2 0.0002
361 PERIPHERAL VASCULAR DISORDER 1 0.0002
362 PERIORBITAL OEDEMA 1 0.0002
363 VENTRICULAR EXTRASYSTOLES 2 0.0002
364 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
365 INTESTINAL RESECTION 1 0.0002
366 RHINORRHOEA 12 0.0002
367 LIMB INJURY 5 0.0002
368 PRODUCT PRESCRIBING ISSUE 4 0.0002
369 WOUND INFECTION 2 0.0002
370 CHOKING SENSATION 1 0.0002
371 ILL-DEFINED DISORDER 11 0.0002
372 PRODUCT LEAKAGE 1 0.0002
373 PERIORBITAL SWELLING 1 0.0002
374 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
375 DEVICE USE ISSUE 3 0.0002
376 BRADYKINESIA 1 0.0002
377 MACULAR DEGENERATION 2 0.0002
378 ENDOPHTHALMITIS 1 0.0002
379 TENSION 1 0.0002
380 SPINAL OPERATION 2 0.0002
381 PIGMENTATION DISORDER 1 0.0002
382 INFUSION SITE EXTRAVASATION 1 0.0002
383 MIDDLE INSOMNIA 3 0.0002
384 DRY MOUTH 13 0.0002
385 NASAL DRYNESS 1 0.0002
386 INFUSION SITE SWELLING 1 0.0002
387 THERAPEUTIC PRODUCT EFFECT DECREASED 7 0.0002
388 ACUTE RESPIRATORY FAILURE 3 0.0002
389 POLYP 1 0.0002
390 NEPHROLITHIASIS 7 0.0002
391 JOINT STIFFNESS 4 0.0002
392 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
393 BLOOD PRESSURE ABNORMAL 3 0.0002
394 APPETITE DISORDER 1 0.0002
395 SKIN MASS 1 0.0001
396 EXTRA DOSE ADMINISTERED 6 0.0001
397 WRONG PRODUCT ADMINISTERED 1 0.0001
398 PRODUCT TASTE ABNORMAL 2 0.0001
399 LYMPHOEDEMA 1 0.0001
400 HAIR GROWTH ABNORMAL 1 0.0001
401 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 29 0.0001
402 RASH MACULAR 5 0.0001
403 DEFAECATION URGENCY 1 0.0001
404 INTENTIONAL DOSE OMISSION 4 0.0001
405 FEAR OF INJECTION 1 0.0001
406 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
407 PRODUCT USE ISSUE 26 0.0001
408 PRODUCT DISPENSING ERROR 3 0.0001
409 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
410 ORAL DISORDER 1 0.0001
411 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
412 BLINDNESS TRANSIENT 1 0.0001
413 SENSITIVE SKIN 1 0.0001
414 PSYCHIATRIC SYMPTOM 1 0.0001
415 FEELING DRUNK 1 0.0001
416 SNEEZING 3 0.0001
417 PAROSMIA 1 0.0001
418 TROPONIN INCREASED 1 0.0001
419 PRODUCT DOSE OMISSION ISSUE 37 0.0001
420 SCIATICA 2 0.0001
421 MIOSIS 1 0.0001
422 HYPERSENSITIVITY 23 0.0001
423 MYASTHENIA GRAVIS 1 0.0001
424 DECUBITUS ULCER 1 0.0001
425 SPINAL COMPRESSION FRACTURE 1 0.0001
426 CATARACT 7 0.0001
427 FACIAL PARALYSIS 1 0.0001
428 SKIN HYPERPIGMENTATION 1 0.0001
429 CARDIAC OPERATION 1 0.0001
430 SKIN SWELLING 1 0.0001
431 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
432 PRODUCT COMMUNICATION ISSUE 1 0.0001
433 PURPURA 1 0.0001
434 HAEMOLYTIC ANAEMIA 1 0.0001
435 GASTROINTESTINAL INFECTION 1 0.0001
436 ANAL INCONTINENCE 1 0.0001
437 PNEUMONITIS 3 0.0001
438 OPTIC NEURITIS 1 0.0001
439 BONE DISORDER 2 0.0001
440 EXOSTOSIS 1 0.0001
441 SKIN IRRITATION 5 0.0001
442 DYSURIA 4 0.0001
443 UROSEPSIS 1 0.0001
444 PERSONALITY CHANGE 1 0.0001
445 SKIN EXFOLIATION 9 0.0001
446 DYSPNOEA EXERTIONAL 4 0.0001
447 HALLUCINATION 8 0.0001
448 SPUTUM DISCOLOURED 1 0.0001
449 PRODUCT PACKAGING ISSUE 1 0.0001
450 RED BLOOD CELL COUNT DECREASED 3 0.0001
451 PRODUCTIVE COUGH 5 0.0001
452 ANGINA PECTORIS 3 0.0001
453 BLOOD PRESSURE INCREASED 16 0.0001
454 BALANCE DISORDER 9 0.0001
455 EAR PAIN 2 0.0001
456 INTENTIONAL PRODUCT USE ISSUE 9 0.0001
457 VITAMIN D DEFICIENCY 1 0.0001
458 PALPITATIONS 12 0.0001
459 SURGERY 6 0.0001
460 HEPATOMEGALY 1 0.0001
461 THERAPY CHANGE 1 0.0001
462 DISABILITY 2 0.0001
463 VERTIGO 6 0.0001
464 MOTOR DYSFUNCTION 1 0.0001
465 BODY TEMPERATURE INCREASED 2 0.0001
466 OROPHARYNGEAL PAIN 9 0.0001
467 TENDERNESS 1 0.0001
468 PRODUCT ODOUR ABNORMAL 1 0.0001
469 TRANSFUSION 1 0.0001
470 SPEECH DISORDER 5 0.0001
471 DERMATITIS ATOPIC 5 0.0001
472 SCRATCH 1 0.0001
473 HALLUCINATION, VISUAL 2 0.0001
474 INCONTINENCE 1 0.0001
475 JOINT DISLOCATION 1 0.0001
476 RENAL PAIN 1 0.0001
477 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
478 BREAST PAIN 1 0.0001
479 IMPAIRED WORK ABILITY 2 0.0001
480 DRUG INTOLERANCE 9 0.0001
481 SKIN CANCER 2 0.0001
482 DECREASED ACTIVITY 1 0.0001
483 BIPOLAR DISORDER 1 0.0001
484 NERVE INJURY 1 0.0001
485 BLISTER 5 0.0001
486 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
487 HEART RATE IRREGULAR 2 0.0001
488 SKIN DISCOLOURATION 4 0.0001
489 ADVERSE EVENT 8 0.0001
490 UPPER RESPIRATORY TRACT INFECTION 4 0.0001
491 HEART RATE DECREASED 3 0.0001
492 NASAL CONGESTION 5 0.0001
493 COVID-19 PNEUMONIA 1 0.0001
494 HOSPITALISATION 13 0.0001
495 ARRHYTHMIA 4 0.0001
496 NEUROPATHY PERIPHERAL 8 0.0001
497 ACCIDENT 1 0.0001
498 HYPERLIPIDAEMIA 1 0.0001
499 DIABETIC KETOACIDOSIS 2 0.0001
500 ERYTHEMA 17 0.0001
501 CYST 1 0.0001
502 HAIR COLOUR CHANGES 1 0.0001
503 SECRETION DISCHARGE 1 0.0001
504 CONDITION AGGRAVATED 24 0.0001
505 MUSCLE ATROPHY 1 0.0001
506 ILLNESS 8 0.0001
507 INFUSION SITE PAIN 1 0.0001
508 SKIN ULCER 2 0.0001
509 RESPIRATORY TRACT INFECTION 2 0.0001
510 PLATELET COUNT INCREASED 1 0.0001
511 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
512 BEDRIDDEN 1 0.0001
513 SARS-COV-2 TEST POSITIVE 1 0.0001
514 EYE HAEMORRHAGE 1 0.0001
515 HAIR TEXTURE ABNORMAL 1 0.0001
516 FREQUENT BOWEL MOVEMENTS 2 0.0001
517 SINUS CONGESTION 1 0.0001
518 IMPAIRED GASTRIC EMPTYING 1 0.0001
519 TREATMENT NONCOMPLIANCE 4 0.0001
520 DIVERTICULITIS 2 0.0001
521 FEELING COLD 2 0.0001
522 INSOMNIA 19 0.0001
523 SLEEP DISORDER 5 0.0001
524 HEART RATE INCREASED 7 0.0001
525 PAIN IN JAW 2 0.0001
526 DIALYSIS 1 0.0001
527 DIZZINESS 35 0.0001
528 IMPAIRED QUALITY OF LIFE 1 0.0001
529 INFECTION 10 0.0001
530 ANOSMIA 1 0.0001
531 HYPERTHYROIDISM 1 0.0001
532 HEADACHE 43 0.0001
533 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
534 CONFUSIONAL STATE 11 0.0001
535 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
536 COLON CANCER 1 0.0001
537 IMMUNODEFICIENCY 1 0.0001
538 GASTROINTESTINAL DISORDER 6 0.0001
539 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
540 RESPIRATORY DISORDER 2 0.0001
541 ADVERSE DRUG REACTION 6 0.0001
542 THERAPY NON-RESPONDER 3 0.0001
543 HOT FLUSH 5 0.0001
544 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
545 ABDOMINAL DISCOMFORT 11 0.0001
546 DISCOMFORT 4 0.0001
547 TINNITUS 3 0.0001
548 DEVICE ADHESION ISSUE 1 0.0001
549 PRURITUS 25 0.0001
550 PRODUCT USE IN UNAPPROVED INDICATION 16 0.0001
551 BLOOD CHOLESTEROL INCREASED 3 0.0001
552 RASH 28 0.0001
553 COUGH 18 0.0001
554 THERAPY PARTIAL RESPONDER 1 0.0001
555 HEAD INJURY 2 0.0001
556 MIGRAINE 6 0.0001
557 RASH ERYTHEMATOUS 3 0.0001
558 LOSS OF CONSCIOUSNESS 8 0.0001
559 SENSORY DISTURBANCE 1 0.0001
560 HIP FRACTURE 2 0.0001
561 GASTROOESOPHAGEAL REFLUX DISEASE 5 0.0001
562 PAIN 38 0.0001
563 OFF LABEL USE 54 0.0001
564 BLOOD POTASSIUM INCREASED 1 0.0001
565 BACK DISORDER 1 0.0001
566 HYPERTENSION 13 0.0001
567 URTICARIA 10 0.0001
568 CELLULITIS 3 0.0001
569 PERICARDITIS 1 0.0001
570 FACE OEDEMA 1 0.0001
571 FLUID RETENTION 3 0.0001
572 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
573 URINARY TRACT INFECTION 10 0.0001
574 SINUSITIS 6 0.0001
575 THERAPY CESSATION 3 0.0001
576 HAEMOGLOBIN DECREASED 6 0.0001
577 SCAR 1 0.0001
578 INFLAMMATION 3 0.0001
579 DEVICE DEFECTIVE 1 0.0001
580 ABDOMINAL DISTENSION 6 0.0001
581 GAIT DISTURBANCE 11 0.0001
582 ECZEMA 3 0.0001
583 PARAESTHESIA 9 0.0001
584 SYRINGE ISSUE 1 0.0001
585 EOSINOPHILIA 1 0.0001
586 HYPERKALAEMIA 2 0.0001
587 COVID-19 10 0.0001
588 DEPRESSED MOOD 3 0.0001
589 BRADYCARDIA 3 0.0001
590 HEAD DISCOMFORT 1 0.0001
591 ASPARTATE AMINOTRANSFERASE INCREASED 3 0.0001
592 THIRST 1 0.0001
593 FATIGUE 43 0.0001
594 DRUG EFFECT INCOMPLETE 2 0.0001
595 ACCIDENTAL OVERDOSE 2 0.0001
596 FEELING ABNORMAL 13 0.0001
597 BLOOD SODIUM DECREASED 1 0.0001
598 ARTHRALGIA 22 0.0001
599 FEELING JITTERY 1 0.0001
600 INCREASED APPETITE 1 0.0001
601 DEATH 45 0.0001
602 HERPES ZOSTER 3 0.0001
603 LOWER LIMB FRACTURE 1 0.0001
604 ERUCTATION 1 0.0001
605 PRESCRIBED OVERDOSE 1 0.0001
606 ATRIAL FIBRILLATION 5 0.0001
607 HAEMORRHOIDS 1 0.0001
608 PLASMA CELL MYELOMA 2 0.0001
609 SKIN FISSURES 1 0.0001
610 ARTHRITIS 4 0.0001
611 CONSTIPATION 11 0.0001
612 HAEMATOCRIT DECREASED 1 0.0001
613 UPPER LIMB FRACTURE 1 0.0001
614 SYNCOPE 5 0.0000
615 IRRITABILITY 3 0.0000
616 FULL BLOOD COUNT DECREASED 1 0.0000
617 DIARRHOEA 32 0.0000
618 PRODUCT PHYSICAL ISSUE 1 0.0000
619 PSORIATIC ARTHROPATHY 2 0.0000
620 ANXIETY 14 0.0000
621 MUSCLE SPASMS 9 0.0000
622 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
623 PRODUCT PREPARATION ERROR 1 0.0000
624 RIB FRACTURE 1 0.0000
625 DEPRESSION 11 0.0000
626 FALL 16 0.0000
627 POLLAKIURIA 2 0.0000
628 ROAD TRAFFIC ACCIDENT 2 0.0000
629 DERMATITIS 1 0.0000
630 DYSPNOEA 27 0.0000
631 CEREBROVASCULAR ACCIDENT 8 0.0000
632 EATING DISORDER 1 0.0000
633 PLATELET COUNT DECREASED 5 0.0000
634 RETCHING 1 0.0000
635 JOINT INJURY 1 0.0000
636 IRRITABLE BOWEL SYNDROME 1 0.0000
637 LIVER FUNCTION TEST INCREASED 1 0.0000
638 HYPERHIDROSIS 6 0.0000
639 RECTAL HAEMORRHAGE 2 0.0000
640 DRUG INEFFECTIVE 61 0.0000
641 FAECES DISCOLOURED 1 0.0000
642 SWELLING FACE 3 0.0000
643 DEVICE DISLOCATION 2 0.0000
644 INTENTIONAL PRODUCT MISUSE 4 0.0000
645 PERIPHERAL SWELLING 7 0.0000
646 APPLICATION SITE PAIN 1 0.0000
647 INFUSION RELATED REACTION 3 0.0000
648 BLOOD PRESSURE DECREASED 3 0.0000
649 HYPOTENSION 9 0.0000
650 INFLUENZA 5 0.0000
651 COLITIS ULCERATIVE 2 0.0000
652 THROAT IRRITATION 2 0.0000
653 PAIN IN EXTREMITY 13 0.0000
654 MUSCULAR WEAKNESS 5 0.0000
655 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
656 PERICARDIAL EFFUSION 1 0.0000
657 CHEST PAIN 8 0.0000
658 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3 0.0000
659 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
660 HEPATIC CANCER 1 0.0000
661 LOCALISED INFECTION 1 0.0000
662 MYALGIA 7 0.0000
663 FIBROMYALGIA 1 0.0000
664 PRESYNCOPE 1 0.0000
665 NEURALGIA 1 0.0000
666 DYSGEUSIA 3 0.0000
667 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
668 EPISTAXIS 3 0.0000
669 AGEUSIA 1 0.0000
670 HYPOAESTHESIA 6 0.0000
671 PNEUMONIA ASPIRATION 1 0.0000
672 LEUKOPENIA 2 0.0000
673 ABDOMINAL PAIN LOWER 1 0.0000
674 WEIGHT DECREASED 11 0.0000
675 CARDIOVASCULAR DISORDER 1 0.0000
676 HYPOPHAGIA 1 0.0000
677 HEPATITIS 1 0.0000
678 ANAPHYLACTIC SHOCK 1 0.0000
679 UNRESPONSIVE TO STIMULI 1 0.0000
680 NO ADVERSE EVENT 7 0.0000
681 NERVOUSNESS 2 0.0000
682 DEAFNESS 1 0.0000
683 NASOPHARYNGITIS 7 0.0000
684 NAUSEA 30 0.0000
685 PANCREATITIS 2 0.0000
686 DRY SKIN 5 0.0000
687 FEAR 1 0.0000
688 BLOOD GLUCOSE INCREASED 7 0.0000
689 PAIN OF SKIN 1 0.0000
690 DISTURBANCE IN ATTENTION 2 0.0000
691 RASH PRURITIC 2 0.0000
692 SKIN LESION 1 0.0000
693 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
694 ABNORMAL DREAMS 1 0.0000
695 ARTHROPATHY 2 0.0000
696 NECK PAIN 2 0.0000
697 DEMENTIA 1 0.0000
698 INCORRECT DOSE ADMINISTERED 8 0.0000
699 HYPERSOMNIA 1 0.0000
700 PRODUCT SUBSTITUTION ISSUE 2 0.0000
701 PANCREATIC CARCINOMA 1 0.0000
702 DECREASED APPETITE 8 0.0000
703 NEEDLE ISSUE 1 0.0000
704 DYSSTASIA 1 0.0000
705 BONE PAIN 2 0.0000
706 ABDOMINAL PAIN UPPER 7 0.0000
707 OESOPHAGEAL CARCINOMA 1 0.0000
708 EMOTIONAL DISTRESS 4 0.0000
709 FEELING HOT 2 0.0000
710 INJECTION SITE RASH 1 0.0000
711 FEMUR FRACTURE 1 0.0000
712 NERVOUS SYSTEM DISORDER 1 0.0000
713 MALAISE 14 0.0000
714 ASTHENIA 12 0.0000
715 DRUG-INDUCED LIVER INJURY 1 0.0000
716 DYSPHAGIA 3 0.0000
717 MOOD SWINGS 1 0.0000
718 WEIGHT INCREASED 7 0.0000
719 MOVEMENT DISORDER 1 0.0000
720 NIGHT SWEATS 1 0.0000
721 PRODUCT DOSE OMISSION 2 0.0000
722 CHOLELITHIASIS 1 0.0000
723 DYSPEPSIA 3 0.0000
724 OSTEONECROSIS 1 0.0000
725 ABDOMINAL PAIN 7 0.0000
726 LIP SWELLING 1 0.0000
727 FUNGAL INFECTION 1 0.0000
728 DEHYDRATION 4 0.0000
729 GAIT INABILITY 1 0.0000
730 SOMNOLENCE 6 0.0000
731 ANGER 1 0.0000
732 DELIRIUM 1 0.0000
733 HYPOXIA 1 0.0000
734 LYMPHADENOPATHY 1 0.0000
735 CEREBRAL HAEMORRHAGE 1 0.0000
736 C-REACTIVE PROTEIN INCREASED 1 0.0000
737 HYPERGLYCAEMIA 1 0.0000
738 PANIC ATTACK 1 0.0000
739 RESTLESSNESS 1 0.0000
740 INJECTION SITE MASS 1 0.0000
741 ASTHMA 3 0.0000
742 INTESTINAL OBSTRUCTION 1 0.0000
743 RHEUMATOID ARTHRITIS 3 0.0000
744 COLITIS 1 0.0000
745 INJECTION SITE SWELLING 2 0.0000
746 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
747 CHILLS 3 0.0000
748 VOMITING 12 0.0000
749 DISORIENTATION 1 0.0000
750 DRUG INTERACTION 4 0.0000
751 THROMBOSIS 2 0.0000
752 JOINT SWELLING 3 0.0000
753 PNEUMONIA 8 0.0000
754 OSTEOPOROSIS 1 0.0000
755 TREMOR 4 0.0000
756 SEPTIC SHOCK 1 0.0000
757 ANGIOEDEMA 1 0.0000
758 PULMONARY OEDEMA 1 0.0000
759 NEUTROPENIA 3 0.0000
760 SUICIDAL IDEATION 2 0.0000
761 BACK PAIN 5 0.0000
762 RENAL DISORDER 1 0.0000
763 BREAST CANCER 2 0.0000
764 COGNITIVE DISORDER 1 0.0000
765 DISEASE RECURRENCE 1 0.0000
766 ANAEMIA 4 0.0000
767 BLOOD GLUCOSE DECREASED 1 0.0000
768 CONTUSION 2 0.0000
769 LUNG DISORDER 1 0.0000
770 ALOPECIA 4 0.0000
771 FLUSHING 2 0.0000
772 CHEST DISCOMFORT 2 0.0000
773 HAEMORRHAGE 2 0.0000
774 MUSCULOSKELETAL PAIN 1 0.0000
775 OEDEMA 1 0.0000
776 ANAPHYLACTIC REACTION 1 0.0000
777 FLATULENCE 1 0.0000
778 LETHARGY 1 0.0000
779 DYSPHONIA 1 0.0000
780 DISEASE PROGRESSION 2 0.0000
781 WHEEZING 1 0.0000
782 THERAPEUTIC RESPONSE DECREASED 1 0.0000
783 STOMATITIS 1 0.0000
784 PLEURAL EFFUSION 1 0.0000
785 DEEP VEIN THROMBOSIS 1 0.0000
786 PSORIASIS 2 0.0000
787 DEVICE DIFFICULT TO USE 1 0.0000
788 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
789 MEMORY IMPAIRMENT 2 0.0000
790 INJECTION SITE REACTION 1 0.0000
791 PYREXIA 5 0.0000
792 DEVICE MALFUNCTION 1 0.0000
793 INJURY 1 0.0000
794 SKIN BURNING SENSATION 1 0.0000
795 MOBILITY DECREASED 1 0.0000
796 UNDERDOSE 1 0.0000
797 AGITATION 1 0.0000
798 UNEVALUABLE EVENT 1 0.0000
799 CHRONIC KIDNEY DISEASE 1 0.0000
800 DIABETES MELLITUS 1 0.0000
801 INJECTION SITE PAIN 4 0.0000
802 INJECTION SITE HAEMORRHAGE 1 0.0000
803 CARDIAC FAILURE 1 0.0000
804 CARDIAC FAILURE CONGESTIVE 1 0.0000
805 PROSTATE CANCER 1 0.0000
806 INFLUENZA LIKE ILLNESS 1 0.0000
807 TACHYCARDIA 1 0.0000
808 DEVICE ISSUE 1 0.0000
809 CARDIAC DISORDER 1 0.0000
810 SWELLING 1 0.0000
811 PULMONARY EMBOLISM 1 0.0000
812 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
813 SEPSIS 1 0.0000
814 THROMBOCYTOPENIA 1 0.0000
815 SEIZURE 1 0.0000
816 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
817 OEDEMA PERIPHERAL 1 0.0000
818 ACUTE KIDNEY INJURY 1 0.0000
819 MYOCARDIAL INFARCTION 1 0.0000
820 OVERDOSE 1 0.0000